BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 33529162)

  • 1. The knowns and unknowns of latent Mycobacterium tuberculosis infection.
    Boom WH; Schaible UE; Achkar JM
    J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33529162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.
    Adekambi T; Ibegbu CC; Kalokhe AS; Yu T; Ray SM; Rengarajan J
    PLoS One; 2012; 7(4):e36046. PubMed ID: 22545156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent tuberculosis: what the host "sees"?
    Gideon HP; Flynn JL
    Immunol Res; 2011 Aug; 50(2-3):202-12. PubMed ID: 21717066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dormant Mycobacterium tuberculosis fails to block phagosome maturation and shows unexpected capacity to stimulate specific human T lymphocytes.
    Mariotti S; Pardini M; Gagliardi MC; Teloni R; Giannoni F; Fraziano M; Lozupone F; Meschini S; Nisini R
    J Immunol; 2013 Jul; 191(1):274-82. PubMed ID: 23733870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antibody profiles in individuals with latent Mycobacterium tuberculosis infection.
    Maekura R; Kitada S; Osada-Oka M; Tateishi Y; Ozeki Y; Fujicawa T; Miki M; Jyunnko O; Mori M; Matsumoto S
    Microbiol Immunol; 2019 Mar; 63(3-4):130-138. PubMed ID: 30851131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M; Ottenhoff TH
    Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation Phenotype of
    Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
    Front Immunol; 2021; 12():721013. PubMed ID: 34512645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of latent tuberculosis infection-related microRNAs in human U937 macrophages expressing Mycobacterium tuberculosis Hsp16.3.
    Meng QL; Liu F; Yang XY; Liu XM; Zhang X; Zhang C; Zhang ZD
    BMC Microbiol; 2014 Feb; 14():37. PubMed ID: 24521422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host immunity to Mycobacterium tuberculosis and risk of tuberculosis: A longitudinal study among Greenlanders.
    Michelsen SW; Soborg B; Agger EM; Diaz LJ; Hoff ST; Koch A; Sorensen HCF; Andersen P; Wohlfahrt J; Melbye M
    Vaccine; 2016 Nov; 34(48):5975-5983. PubMed ID: 27997344
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Osugi A; Tamaru A; Yoshiyama T; Iwamoto T; Mitarai S; Murase Y
    Microbiol Spectr; 2024 Jul; 12(7):e0428923. PubMed ID: 38786200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 T Cells in
    McLaughlin TA; Khayumbi J; Ongalo J; Tonui J; Campbell A; Allana S; Gurrion Ouma S; Odhiambo FH; Gandhi NR; Day CL
    Front Immunol; 2020; 11():127. PubMed ID: 32117277
    [No Abstract]   [Full Text] [Related]  

  • 13. Latent tuberculosis infection--Revisiting and revising concepts.
    Salgame P; Geadas C; Collins L; Jones-López E; Ellner JJ
    Tuberculosis (Edinb); 2015 Jul; 95(4):373-84. PubMed ID: 26038289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ T-cell-independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection.
    Foreman TW; Mehra S; LoBato DN; Malek A; Alvarez X; Golden NA; Bucşan AN; Didier PJ; Doyle-Meyers LA; Russell-Lodrigue KE; Roy CJ; Blanchard J; Kuroda MJ; Lackner AA; Chan J; Khader SA; Jacobs WR; Kaushal D
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5636-44. PubMed ID: 27601645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease.
    Rozot V; Vigano S; Mazza-Stalder J; Idrizi E; Day CL; Perreau M; Lazor-Blanchet C; Petruccioli E; Hanekom W; Goletti D; Bart PA; Nicod L; Pantaleo G; Harari A
    Eur J Immunol; 2013 Jun; 43(6):1568-77. PubMed ID: 23456989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent TB Infection (LTBI) - Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground.
    Rao M; Ippolito G; Mfinanga S; Ntoumi F; Yeboah-Manu D; Vilaplana C; Zumla A; Maeurer M
    Int J Infect Dis; 2019 Mar; 80S():S58-S61. PubMed ID: 30822547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates.
    Ishida E; Corrigan DT; Chen T; Liu Y; Kim RS; Song L; Rutledge TM; Magee DM; LaBaer J; Lowary TL; Lin PL; Achkar JM
    EBioMedicine; 2024 Jan; 99():104897. PubMed ID: 38096687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.
    Zhao HM; Du R; Li CL; Ji P; Li HC; Wu K; Hu Z; Lu SH; Lowrie DB; Fan XY
    J Infect; 2019 Apr; 78(4):275-280. PubMed ID: 30528871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infection.
    Thiel BA; Worodria W; Nalukwago S; Nsereko M; Sanyu I; Rejani L; Zawedde J; Canaday DH; Stein CM; Chervenak KA; Malone LL; Kiyemba R; Silver RF; Johnson JL; Mayanja-Kizza H; Boom WH
    PLoS One; 2021; 16(4):e0249477. PubMed ID: 33836031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.